Open AccessS961 Risk of New or Recurrent Cancer After Vedolizumab or Ustekinumab Exposure in Patients With Inflammatory Bowel Disease and Previous Cancer
Author(s) -
Cameron Zenger,
Simon Hong,
Jillian Pecoriello,
Alice S. Pang,
Margaret Vallely,
David Hudesman,
Shan Chang,
Jordan E. Axelrad
Publication year - 2021
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000777376.85467.82
Subject(s) - medicine , vedolizumab , ustekinumab , cancer , inflammatory bowel disease , crohn's disease , colorectal cancer , retrospective cohort study , oncology , disease , infliximab